Mineralys Therapeutics, Inc.(MLYS:US)

Market Cap$1.674B

Key Metrics

Price$20.30

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$151.78M

EBITDA (TTM)-$171.45M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$112.78M

Total Assets$652.86M

Net Assets$638.14M

Total Debt$0

Mineralys Therapeutics, Inc.(MLYS:US)

Market Cap$1.674B

Price history

Key Metrics

Price$20.30

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$151.78M

EBITDA (TTM)-$171.45M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$112.78M

Total Assets$652.86M

Net Assets$638.14M

Total Debt$0

Financials

NameMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Revenue
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cost of Revenue
------------------
Gross Profit
------------------
$45.34M$38.28M$41.13M$46.75M$44.45M$51.77M$60.11M$45.17M$35.36M$27.71M$26.27M$15.74M$14.94M$10.01M$7.42M$6.48M$7.57M$7.08M
Research and Development$24.37M$24.4M$31.45M$38.28M$37.88M$44.57M$53.99M$39.27M$30.75M$23.69M$22.5M$11.88M$12.29M$7.82M$6.06M$5.6M$6.78M$6.62M
Selling, General, and Administrative$20.98M$13.88M$9.68M$8.47M$6.57M$7.2M$6.12M$5.9M$4.61M$4.03M$3.77M$3.85M$2.65M$2.19M$1.36M$884K$791K$467K
Other Operating Expenses------------------
Operating Income
-$45.34M-$38.28M-$41.13M-$46.75M-$44.45M-$51.77M-$60.11M-$45.17M-$35.36M-$27.71M-$26.27M-$15.74M-$14.94M-$10.01M-$7.42M-$6.48M-$7.57M-$7.08M
$6M$6.05M$4.2M$3.47M$2.24M$2.82M$3.76M$4.15M$3.85M$3.32M$3.51M$3.59M$2.33M$935K$745K$0$0$0
Non-Operating Interest Income$6M$6.05M$4.2M$3.47M$2.24M$2.81M$3.77M$4.15M$3.85M$3.32M$3.51M$3.59M$2.33M$935K$741K$0$0-
Non-Operating Interest Expense-----------------$0
Other Income/Expense$5K-$4K-$2K-$3K$12K-$10K$2K$1K$1K-$1K$1K$0$4K--$0
Income Before Tax
-$39.34M-$32.23M-$36.93M-$43.27M-$42.21M-$48.95M-$56.34M-$41.01M-$31.51M-$24.39M-$22.76M-$12.14M-$12.61M-$9.07M-$6.68M-$6.48M-$7.57M-$7.08M
Income Tax
------------------
Net Income
-$39.34M-$32.23M-$36.93M-$43.27M-$42.21M-$48.95M-$56.34M-$41.01M-$31.51M-$24.39M-$22.76M-$12.14M-$12.61M-$9.07M-$6.68M-$6.48M-$7.57M-$7.08M
Minority Interests
------------------
Preferred Stock Dividends
------------------
Net Income to Common
-$39.34M-$32.23M-$36.93M-$43.27M-$42.21M-$48.95M-$56.34M-$41.01M-$31.51M-$24.39M-$22.76M-$12.14M-$12.61M-$9.07M-$6.68M-$6.48M-$7.57M-$7.08M
Shares Outstanding (Basic)
82.83M80.55M70.59M65.45M53.16M49.96M49.82M49.36M44.9M-39.93M39.75M24.76M39.06M5.18M5.18M5.18M-
Shares Outstanding (Diluted)
82.83M80.55M70.59M65.45M53.16M49.96M49.82M49.36M44.9M-39.93M39.75M24.76M39.06M5.18M5.18M5.18M-
EPS (Basic)
-$0.47-$0.40-$0.52-$0.66-$0.79-$0.98-$1.13-$0.83-$0.70--$0.57-$0.31-$0.51-$0.23-$1.29-$1.25-$1.46-
EPS (Diluted)
-$0.47-$0.40-$0.52-$0.66-$0.79-$0.98-$1.13-$0.83-$0.70--$0.57-$0.31-$0.51-$0.23-$1.29-$1.25-$1.46-
EBIT
-$45.34M-$38.28M-$41.13M-$46.75M-$44.45M-$51.77M-$60.11M-$45.17M-$35.36M-$27.71M-$26.27M-$15.74M-$14.94M-$10.01M-$7.42M-$6.48M-$7.57M-$7.08M
EBITDA
-$45.33M-$38.27M-$41.12M-$46.73M-$44.43M-$51.75M-$60.1M-$45.16M-$35.35M-$27.71M-$26.27M-$15.74M-$14.94M-$10.01M-$7.42M-$6.48M-$7.57M-$7.08M